The CB2 Cannabinoid System: A New Strategy in Neurodegenerative Disorder and Neuroinflammation

• Päätekijä: Marialessandra Contino (auth)
• Muut tekijät: Nicola A. Colabufo (auth), Elena Capparelli (auth), Ashley I. Bush (auth)
• Aineistotyyppi: Elektroninen Kirjan osa
• Kieli: englanti
• Julkaistu: Frontiers Media SA 2017
• Sarja: Frontiers Research Topics
• Aiheet: Neurosciences; Cannabinod system; CB2 receptor; CB2R inverse; AD; PD; neurodegeneration; CB2R agonist; Inflammation
• Linkit: DOAB: download the publication; DOAB: description of the publication

The neurodegenerative disorders such as Parkinson's disease (PD) or Alzheimer's disease (AD) are the most common forms of dementia and no pharmacological treatments are to date available for these diseases. Indeed, the only used drugs are symptomatic and no useful to block the progression...